Cancer Research Center Signs Multiyear Commitment to OmniComm’s TrialMaster EDC

Article

Applied Clinical Trials

A clinical research center signs a $3.5 Million commitment to TrialMaster EDC and OmniComm Systems, Inc., a global provider of clinical data management technology in hopes to use TrialMaster EDC for clinical data collection to develop patient-centric cancer therapies.

Read the full release here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.